HY-120504-1mL
|
MedChemexpress LLC
|
N-Acetyltyramine [CAS 1202-66-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P7267-10ug
|
MedChemexpress LLC
|
NAP-2/CXCL7, Human (CHO)
|
|
COVID-19-immunoregulation
|
|
HY-P7267-50ug
|
MedChemexpress LLC
|
NAP-2/CXCL7, Human (CHO)
|
|
COVID-19-immunoregulation
|
|
HY-P99035-1mg
|
MedChemexpress LLC
|
Naptumomab [CAS 1412892-09-1]
|
|
COVID-19-immunoregulation
|
|
HY-P99035-10mg
|
MedChemexpress LLC
|
Naptumomab [CAS 1412892-09-1]
|
|
COVID-19-immunoregulation
|
|
HY-P99035-5mg
|
MedChemexpress LLC
|
Naptumomab [CAS 1412892-09-1]
|
|
COVID-19-immunoregulation
|
|
HY-121410-1mg
|
MedChemexpress LLC
|
Narasin [CAS 55134-13-9]
|
|
COVID-19-immunoregulation
|
|
HY-121410-5mg
|
MedChemexpress LLC
|
Narasin [CAS 55134-13-9]
|
|
COVID-19-immunoregulation
|
|
HY-123121-1mg
|
MedChemexpress LLC
|
Nargenicin A1 [CAS 70695-02-2]
|
|
COVID-19-immunoregulation
|
|
HY-123121-5mg
|
MedChemexpress LLC
|
Nargenicin A1 [CAS 70695-02-2]
|
|
COVID-19-immunoregulation
|
|
HY-17639-1mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-10mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-25mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-5mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-126425-2mg
|
MedChemexpress LLC
|
NCGC00262650 [CAS 344359-25-7]
|
|
COVID-19-immunoregulation
|
|
HY-103385-10mg
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2]
|
|
COVID-19-immunoregulation
|
|
HY-103385-100mg
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2]
|
|
COVID-19-immunoregulation
|
|
HY-103385-25mg
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2]
|
|
COVID-19-immunoregulation
|
|
HY-103385-5mg
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2]
|
|
COVID-19-immunoregulation
|
|
HY-103385-50mg
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2]
|
|
COVID-19-immunoregulation
|
|
HY-103385-1mL
|
MedChemexpress LLC
|
NCX4040 [CAS 287118-97-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-N4285-1mg
|
MedChemexpress LLC
|
Negletein [CAS 29550-13-8]
|
|
COVID-19-immunoregulation
|
|
HY-N4285-10mg
|
MedChemexpress LLC
|
Negletein [CAS 29550-13-8]
|
|
COVID-19-immunoregulation
|
|
HY-N4285-5mg
|
MedChemexpress LLC
|
Negletein [CAS 29550-13-8]
|
|
COVID-19-immunoregulation
|
|
HY-P99378-1mg
|
MedChemexpress LLC
|
Neihulizumab [CAS 2158362-38-8]
|
|
COVID-19-immunoregulation
|
|